Abstract:Background and purpose: An increasing number of studies have revealed that microRNAs (miRNAs) are the main drivers of hepatocarcinogenesis including progression to later stages of liver cancer. Recently, miR-548b was identified as a cancer-related miRNA in glioma and tongue squamous cell carcinoma. Nonetheless, the expression pattern and specific roles of miR-548b in hepatocellular carcinoma (HCC) have not yet been clarified. Methods: Expression levels of miR-548b in HCC tissues and cell lines were measured by reverse-transcription quantitative PCR. In vitro and in vivo functional assays were performed to determine the effects of miR-548b on the malignant phenotypes of HCC cells. In addition, the molecular mechanisms by which miR-548b regulates the initiation and progression of HCC were investigated in detail. Results: miR-548b expression was weak in HCC tissues and cell lines. The low miR-548b expression significantly correlated with tumor size, TNM stage, and venous infiltration of HCC. In addition, exogenous miR-548b expression suppressed HCC cell proliferation, colony formation, and metastasis and induced apoptosis in vitro. Silencing of miR-548b exerted an opposite effect on these characteristics of HCC cells. Furthermore, miR-548b overexpression hindered tumor growth in vivo. Mechanistic analysis identified high-mobility group box 1 (HMGB1) as a direct target gene of miR-548b in HCC cells. Moreover, an HMGB1 knockdown reproduced the effects of miR-548b upregulation on HCC cells. Recovered HMGB1 expression reversed the effects of miR-548b on HCC cells. Notably, miR-548b overexpression deactivated the PI3K-AKT pathway in HCC cells in vitro and in vivo. Conclusion: Our findings provide the first evidence that miR-548b restrains HCC progression, at least partially, by downregulating HMGB1 and deactivating the PI3K-AKT pathway. Thus, miR-548b might be a novel target for the development of new therapies for HCC.

Mir‑498 Inhibits the Growth and Metastasis of Liver Cancer by Targeting ZEB2.

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

Mir-154 Targeting ZEB2 in Hepatocellular Carcinoma Functions As a Potential Tumor Suppressor.

[Retracted] MicroRNA‑454 Inhibits Tumor Cell Proliferation, Migration and Invasion by Downregulating Zinc Finger E‑box‑binding Homeobox 1 in Gastric Cancer.

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Mir-141 Targets ZEB2 to Suppress HCC Progression

MicroRNA-204 Suppressed Proliferation and Motility Capacity of Human Hepatocellular Carcinoma Via Directly Targeting Zinc Finger E-box Binding Homeobox 2.

MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395

Mirna-99b-5p Suppresses Liver Metastasis Of Colorectal Cancer By Down-Regulating Mtor

miRNA-346 promotes proliferation, migration and invasion in liver cancer

Mir-1188 at the Imprinted Dlk1-Dio3 Domain Acts As A Tumor Suppressor in Hepatoma Cells

Role of Mir-138 in the Regulation of Larynx Carcinoma Cell Metastases

microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA

Mir-451: Potential Role As Tumor Suppressor of Human Hepatoma Cell Growth and Invasion

MicroRNA‑574‑3p Inhibits the Malignant Behavior of Liver Cancer Cells by Targeting ADAM28

Mir-215 Functions As a Tumor Suppressor and Directly Targets ZEB2 in Human Non-Small Cell Lung Cancer

Mir-598 Inhibits Metastasis in Colorectal Cancer by Suppressing JAG1/Notch2 Pathway Stimulating EMT

Mir-23C Suppresses Tumor Growth of Human Hepatocellular Carcinoma by Attenuating ERBB2IP.

Mir-542-3p Inhibits Metastasis And Epithelial- Mesenchymal Transition Of Hepatocellular Carcinoma By Targeting Ube3c

Lncrna XIST Regulates Proliferation and Migration of Hepatocellular Carcinoma Cells by Acting As Mir-497-5p Molecular Sponge and Targeting PDCD4

Mir-200b/200c/429 Subfamily Negatively Regulates Rho/Rock Signaling Pathway to Suppress Hepatocellular Carcinoma Metastasis